Clinical Trial Update: Safety and Efficacy Study of Microplasmin in for Non-Surgical Treatment of Focal Vitreomacular Adhesion [Phase 2]

View source ↗

Summary

Phase 2 safety and efficacy evaluation of Microplasmin for non-surgical treatment of focal vitreomacular adhesion has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Focal Vitreomacular Adhesion

Drugs mentioned

• microplasmin (microplasmin)

Snippet

Sponsor: ThromboGenics | Conditions: Focal Vitreomacular Adhesion | Phase 2 | Status: COMPLETED